K181044 is an FDA 510(k) clearance for the 400um Perforator and Accessory Vein Ablation Kit. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.
Submitted by AngioDynamics, Inc. (Marlborough, US). The FDA issued a Cleared decision on July 5, 2018 after a review of 77 days - a notably fast clearance cycle.
This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all AngioDynamics, Inc. devices
NCT02215369
Completed
Interventional
Industry-sponsored
SeCure Endovenous Laser Treatment Study
Prospective Safety and Effectiveness Study: VenaCure Endovenous Laser Treatment (EVLT) 400 µm Fiber Procedure Kit for Treatment of Incompetent Perforator Veins
| Condition studied |
Chronic Venous Insufficiency |
| Study design |
Single group |
| Eligibility |
All sexes
· 18 Years+
|
| Sponsor |
Angiodynamics, Inc.
(industry)
|
Started 2015-01-01
→
Primary completion 2018-03-01
→
Completed 2019-01-14
Primary outcome
Acute Primary Ablation Success
Secondary outcome
Technical Success
View full study on ClinicalTrials.gov